[1]徐浩语,王和西,黎楠,等.Renca细胞来源的外泌体活化髓源抑制性细胞对细胞毒性T细胞的抑制效应[J].第三军医大学学报,2019,41(10):923-930.
 XU Haoyu,WANG Hexi,LI Nan,et al.Inhibitory effect of myeloid-derived suppressor cells activated by Renca cell-derived exosomes on mouse cytotoxic T lymphocytes in vitro[J].J Third Mil Med Univ,2019,41(10):923-930.
点击复制

Renca细胞来源的外泌体活化髓源抑制性细胞对细胞毒性T细胞的抑制效应(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第10期
页码:
923-930
栏目:
基础医学
出版日期:
2019-05-30

文章信息/Info

Title:
Inhibitory effect of myeloid-derived suppressor cells activated by Renca cell-derived exosomes on mouse cytotoxic T lymphocytes in vitro
作者:
徐浩语王和西黎楠张尧
重庆医科大学附属第一医院泌尿外科
Author(s):
XU Haoyu WANG Hexi LI Nan ZHANG Yao

Department of Urology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China

关键词:
Renca细胞ExosomesMDSCsCTLs抑制效应
Keywords:
Renca cells exosomes myeloid-derived suppressor cells cytotoxic T lymphocytes inhibitory effect  
分类号:
R392.1;R692.9;R737.11
文献标志码:
A
摘要:

目的 探讨Renca细胞来源的外泌体(exosomes)活化的髓源抑制性细胞(myeloid-derived suppressor cells, MDSCs)对肾癌抗原特异性细胞毒性T细胞(cytotoxic lymphocytes, CTLs)体外增殖和杀伤效应的抑制作用。方法 超速离心法从Renca细胞无血清上清液中提取出exosomes,流式细胞术检测exosomes对MDSCs的活化效应。分离并培养小鼠树突状细胞(dendritic cells, DCs)和CD8+T细胞,制备DCs活化的肾癌抗原特异性CTLs。磁珠分选exosomes活化的MDSCs,羧基荧光素乙酰乙酸琥珀酰亚胺酯(carboxyfluorescein diacetate succinimidyl ester,CFSE)荧光染色和流式细胞术检测MDSCs对CTLs增殖的抑制作用。将MDSCs、CTLs和Renca细胞体外共培养,乳酸脱氢酶(lactate dehydrogenase, LDH)释放实验检测exosomes活化的MDSCs对CTLs杀伤效应的抑制作用。结果 Renca细胞来源的exosomes有效地诱导了MDSCs的聚集,成功制备了DCs并获得了DCs诱导的肾癌抗原特异性CTLs。与exosomes活化的MDSCs共培养后的CTLs其增殖指数和杀伤率明显低于与未活化的MDSCs共培养后的CTLs和单独的CTLs(P<0.05)。结论 Renca细胞来源的exosomes活化的MDSCs抑制了肾癌抗原特异性CTLs的体外增殖和杀伤效应,可能在肾癌免疫逃逸中扮演重要作用。

 

Abstract:

Objective To investigate the inhibitory effect of myeloid-derived suppressor cells (MDSCs) activated by exosomes derived from Renca cells on the proliferation and killing activity of renal cancer antigen-specific cytotoxic T lymphocytes (CTLs) in vitro. Methods Exosomes derived from Renca cells were purified by ultracentrifugation, and exosome-induced activation of MDSCs was detected using flow cytometry. Mouse dendritic cells (DCs) and CD8+ T cells were isolated to prepare DC-activated renal cancer antigen-specific CTLs. Magnetic beads were used to sort out MDSCs activated by the exosomes, and fluorescence staining with carboxyfluorescein diacetate succinimidyl ester (CFSE) and flow cytometry were performed to assess the inhibitory effect of activated MDSCs on the proliferation of CTLs. MDSCs, CTLs and Renca cells were co-cultured in vitro, and the inhibitory effect of exosomes-activated MDSCs on the killing activity of CTLs was observed using LDH release assay. Results Renca cell-derived exosomes effectively induced the aggregation of MDSCs. We successfully isolated DCs from the mice and obtained DC-activated renal cancer antigen-specific CTLs. Compared with the CTLs cultured alone or in the presence of unactivated MDSCs, the CTLs co-cultured with exosomes-activated MDSCs showed a significantly lower proliferation index and a lower killing rate against Renca cells (P<0.05). Conclusion MDSCs activated by Renca cell-derived exosomes can inhibit the proliferation and lower the cell-killing efficiency of renal cancer antigen-specific CTLs in vitro, suggesting a significant role of MDSCs in immune escape of renal cancer.

参考文献/References:

[1]SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30. DOI:  10.3322/caac.21387.
[2]KUUSK T, GRIVAS N, DE BRUIJN R, et al. The current management of renal cell carcinoma[J]. Minerva Med, 2017, 108(4): 357-369. DOI:  10.23736/S0026-4806.17.05058-3.
[3]DIAO J, YANG X, SONG X, et al. Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3[J]. Med Oncol, 2015, 32(2): 453. DOI:  10.1007/s12032-014-0453-2.
[4]DOMENIS R, CESSELLI D, TOFFOLETTO B, et al. Systemic T cells immunosuppression of glioma stem cell-derived exosomes is mediated by monocytic myeloid-derived suppressor cells[J]. PLoS ONE, 2017,12(1): e0169932. DOI:  10.1371/journal.pone.0169932.
[5]WANG J, DE VEIRMAN K, FAICT S, et al. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression[J]. J Pathol, 2016, 239(2): 162-173. DOI:  10.1002/path.4712.
[6]YAMASHITA T, TAKAHASHI Y, NISHIKAWA M, et al. Effect of exosome isolation methods on physicochemical properties of exosomes and clearance of exosomes from the blood circulation[J]. Eur J Pharm Biopharm, 2016, 98: 1-8. DOI:  10.1016/j.ejpb.2015.10.017.
[7]YAO Y, CHEN L, WEI W, et al. Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities[J]. Biochem Biophys Res Commun, 2013, 436(1): 60-65. DOI:  10.1016/j.bbrc.2013.05.058.
[8]周维英. 肿瘤研究的新焦点——外体[J]. 第三军医大学学报, 2015, 38(1): 1-7. DOI: 10.16016/j.1000-5404. 20150507.
ZHOU W Y. New focus in cancer research:  exosomes[J]. J Third Mil Med Univ, 2015, 38(1):  1-7. DOI: 10.16016/j.1000-5404.20150507.
[9]GUO X, QIU W, LIU Q, et al. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten pathways[J]. Oncogene, 2018, 37(31): 4239-4259. DOI:  10.1038/s41388-018-0261-9.
[10]CHALMIN F, LADOIRE S, MIGNOT G, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells[J]. J Clin Invest, 2010, 120(2): 457-471. DOI:  10.1172/JCI40483.
[11]XIANG X, POLIAKOV A, LIU C, et al. Induction of myeloid-derived suppressor cells by tumor exosomes[J]. Int J Cancer, 2009, 124(11): 2621-2633. DOI:  10.1002/ijc.24249.
[12]MAEDA A, KAWAMURA T, UENO T, et al. Monocytic suppressor cells derived from human peripheral blood suppress xenogenic immune reactions[J]. Xenotransplantation. 2014, 21(1): 46-56. DOI:  10.1111/xen.12067.
[13]GABRILOVICH D I, OSTRAND-ROSENBERG S, BRONTE V. Coordinated regulation of myeloid cells by tumours[J]. Nat Rev Immunol. 2012, 12(4): 253-268. DOI:  10.1038/nri3175.
[14]刘晓玲, 郭红月, 董 猛, 等. 小鼠骨髓树突状细胞体外培养扩增与生物学特性研究[J]. 肿瘤预防与治疗, 2014, 27(1): 1-5. DOI:  10. 3969/ j. issn. 1674-0904. 2014. 01. 001.
LIU X L, GUO H Y, DONG M,et al. Amplification in Vitro and Identification of Biological Characteristics of Dendritic Cell from Mouse Bone Marrow[J]. J Cancer Control Treat, 2014, 27(1): 1-5. DOI:  10. 3969/j.issn. 1674-0904. 2014. 01. 001.
[15]BRUNS H, BTTCHER M, QORRAJ M, et al. CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D[J]. Leukemia, 2017, 31(4): 985-988. DOI:  10.1038/leu.2016.378.
[16]CZERNEK L, DCHLER M. Functions of cancer-derived extracellular vesicles in immunosuppression[J]. Arch Immunol Ther Exp (Warsz), 2017, 65(4): 311-323. DOI:  10.1007/s00005-016-0453-3.
[17]NING Y, SHEN K, WU Q, et al. Tumor exosomes block dendritic cells maturation to decrease the T cell immune response[J]. Immunol Lett, 2018, 199: 36-43. DOI:  10.1016/j.imlet.2018.05.002.
[18]Katsiougiannis S, Chia D, Kim Y, et al. Saliva exosomes from pancreatic tumor-bearing mice modulate NK cell phenotype and antitumor cytotoxicity[J]. FASEB J, 2017, 31(3): 998-1010. DOI:  10.1096/fj.201600984R.
 

相似文献/References:

[1]杨林,吴小候,罗春丽,等.肾癌细胞来源的exosomes诱导Jurkat T细胞凋亡[J].第三军医大学学报,2013,35(05):426.
 Yang Lin,Wu Xiaohou,Luo Chunli,et al.Exosomes derived from renal cancer cells induce Jurkat T cell apoptosis in vitro[J].J Third Mil Med Univ,2013,35(10):426.
[2]刘安全,吴小候,罗春丽.HepaCAM蛋白通过exosomes途径分泌到细胞外并抑制肿瘤细胞增殖[J].第三军医大学学报,2012,34(02):168.
 Liu Anquan,Wu Xiaohou,Luo Chunli.HepaCAM secreted by renal cell carcinoma 786-0 cells through exosomes pathway inhibits cell proliferation[J].J Third Mil Med Univ,2012,34(10):168.
[3]张俊,吴小候,陈刚,等.肾细胞癌源性exosomes体外诱导单核细胞分化为PD-L1髓源性抑制细胞[J].第三军医大学学报,2012,34(02):172.
 Zhang Jun,Wu Xiaohou,Chen Gang,et al.Renal cell carcinoma-derived exosomes induce monocytes to differentiate into PD-L1 myeloid derived suppressor cells in vitro[J].J Third Mil Med Univ,2012,34(10):172.

更新日期/Last Update: 2019-05-24